"6"^^ . "chronic kidney disease; diabetes; hypertension; urinary protein excretion; glomerular filtration rate"@en . . . "2010-01-01+01:00"^^ . "[20EAFED2D6CC]" . "1"^^ . "Ren\u00E1ln\u00ED v\u00FDstupy ze studi\u00ED ONTARGET, TRANCEND a ADVANCE"@cs . "Ren\u00E1ln\u00ED v\u00FDstupy ze studi\u00ED ONTARGET, TRANCEND a ADVANCE" . "1"^^ . . "V\u00FDsledky studi\u00ED ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial), TRANCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease) a ADVANCE (Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation trial) jsou v\u00FDznamn\u00E9 pro l\u00E9\u010Dbu diabetick\u00FDch a nediabetick\u00FDch nemocn\u00FDch s\u00A0chronick\u00FDm onemocn\u011Bn\u00EDm ledvin. P\u0159edev\u0161\u00EDm jde o vliv antihypertenzn\u00ED l\u00E9\u010Dby na vylu\u010Dov\u00E1n\u00ED b\u00EDlkovin mo\u010D\u00ED a glomerul\u00E1rn\u00ED funkci ledvin."@cs . . "RIV/61383082:_____/10:1535!RIV11-MO0-61383082" . "Renal data output from ONTARGET, TRANCEND and ADVANCE trials"@en . . "V" . "Triton" . "Ren\u00E1ln\u00ED v\u00FDstupy ze studi\u00ED ONTARGET, TRANCEND a ADVANCE"@cs . . . "Ren\u00E1ln\u00ED v\u00FDstupy ze studi\u00ED ONTARGET, TRANCEND a ADVANCE" . "Renal data output from ONTARGET, TRANCEND and ADVANCE trials"@en . . . . . "284780" . . . . "Praha" . "Sborn\u00EDk : Widimsk\u00FD, J. jr. a kol. Arteri\u00E1ln\u00ED hypertenze - sou\u010Dasn\u00E9 klinick\u00E9 trendy" . "Praha" . "978-80-7387-362-2" . "V\u00FDsledky studi\u00ED ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial), TRANCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease) a ADVANCE (Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation trial) jsou v\u00FDznamn\u00E9 pro l\u00E9\u010Dbu diabetick\u00FDch a nediabetick\u00FDch nemocn\u00FDch s\u00A0chronick\u00FDm onemocn\u011Bn\u00EDm ledvin. P\u0159edev\u0161\u00EDm jde o vliv antihypertenzn\u00ED l\u00E9\u010Dby na vylu\u010Dov\u00E1n\u00ED b\u00EDlkovin mo\u010D\u00ED a glomerul\u00E1rn\u00ED funkci ledvin." . "RIV/61383082:_____/10:1535" . "Monhart, V\u00E1clav" . . . "Results of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial), TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease) and ADVANCE (Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation trial) trials are important for the treatment of diabetic and non-diabetic patients with chronic kidney disease. First of all there is the influence of antihypertensive therapy on urinary protein excretion and glomerular filtration rate."@en . .